Reports
Sale
Global Stem Cell Market Size, Price, Analysis: By Type: Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells; By Application: Regenerative Medicine, Drug Discovery and Development; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Stem Cell Market Outlook
The global stem cell market size was valued at USD 19.41 billion in 2023, driven by the rising prevalence of various non-communicable diseases, the increasing investments in stem cell therapies, and the growing utilization of human-induced pluripotent stem cells (iPSCs). The market is anticipated to grow at a CAGR of 14.5% during the forecast period of 2024-2032 to achieve a value of USD 63.05 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence of Regenerative Medicines Boosting the Market Growth of Stem Cell
The increasing activities to use stem cells in regenerative medicines owing to their therapeutic properties are augmenting the growth of the stem cell industry. The growing utilisation of human-induced pluripotent stem cells (iPSCs) for the treatment of various inherited heart complications, neurological disorders, and genetic diseases like recessive dystrophic epidermolysis bullosa (RBED) is significantly contributing to the market growth. Moreover, human-induced pluripotent stem cells (iPSCs) can eliminate immunosuppression, due to which they function as a significant source of cells for autologic stem cell therapy, therefore bolstering the industry growth. In addition, the increasing incentives provided by the leading companies to deliver breakthrough therapy for stem cells to surge the utilisation of advanced resources and tools in research and development activities (R&D) is providing impetus to the market growth of stem cell.
North America to Hold a Significant Share of the Stem Cell Industry
North America accounts for a considerable share of the overall stem cell industry owing to the increasing research and development (R&D) in the United States and Canada. Moreover, the rising prevalence of non-communicable chronic diseases, such as cancer and Parkinson’s, among others, is surging the deployment of stem cell treatment, which is strengthening the industry growth. Moreover, the robust healthcare sector in the region is increasing the accessibility for advanced cell therapy treatments, hence aiding the growth of the regional stem cell industry. Apart from this, the Asia Pacific region is expected to grow rapidly due to the rising use of regenerative medicines. Moreover, surging clinical trials owing to cheap labour costs and the availability of raw materials in the region is aiding the market growth, therefore significantly contributing to the overall industry growth.
Stem Cell: Market Segmentation
A stem cell is a cell that can develop various cells ranging from brain cells to muscle cells. It can also aid in fixing damaged tissues. As stem cells have the potential to treat various non-communicable and chronic diseases, such as Alzheimer’s and diabetes, among others, they are employed in various medical and biotechnological research activities to repair tissue damage caused by diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major product types of stem cell are:
- Adult Stem Cell
- Human Embryonic Cell
- Pluripotent Stem Cell
- Others
The market can be broadly categorised on the basis of its treatment types into:
- Allogeneic Stem Cell Therapy
- Autologic Stem Cell Therapy
- Syngeneic Stem Cell Therapy
Based on applications, the market is divided into:
- Neurological Disorders
- Orthopaedic Treatments
- Oncology Disorders
- Injuries and Wounds
- Cardiovascular Disorders
- Others
The EMR report looks into the regional markets of stem cell like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Technological Advancements to Bolster the Market Growth of Stem Cell
Increasing research activities in regenerative medicines and biotechnology to personalise stem cell therapy is anticipated to propel the market growth. The rising demand for treatment of prevalent issues, such as age-related macular degeneration (AMD), among the growing geriatric population is expected to increase the use of stem cells. As each cell posits individual characteristics, it becomes very difficult to characterise cell products due to various error bars during research activities. This is consequently surging the integration of the latest technologies, such as artificial intelligence (AI), blockchain, and machine learning. The use of artificial intelligence (AI) to rapidly analyse images, predict cell functions, and classify tissues to identify cell products, which is estimated to augment the market growth.
The increasing prevalence of cancer and cancer-related research projects is increasing the use of blockchain technology to collect and assimilate data to enhance the accessibility to clinical results and the latest developments. Blockchain can also aid in storing patients’ data efficiently while enhancing the cost-effectiveness of cord-blood banking for advanced research and development (R&D) activities. Moreover, the integration of machine learning algorithms to analyse images and infer the correlation between cellular structures is bolstering the market growth. The growing interest in comprehending processes at a cellular level and identify crucial processes using deep learning is projected to propel the growth of the stem cell industry.
Key Industry Players in the Global Stem Cell Market
The report presents a detailed analysis of the following key players in the global stem cell market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Pluristem Therapeutics Inc.
- Thermo Fisher Scientific Inc.
- Cellular Engineering Technologies
- Merck KGaA
- Becton, Dickinson and Company
- STEMCELL Technologies Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stem Cell Market Overview
3.1 Global Stem Cell Market Historical Value (2017-2023)
3.2 Global Stem Cell Market Forecast Value (2024-2032)
4 Global Stem Cell Market Landscape
4.1 Global Stem Cell Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stem Cell Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Stem Cell Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stem Cell Market Segmentation
6.1 Global Stem Cell Market by Type
6.1.1 Market Overview
6.1.2 Adult Stem Cells (ASCs)
6.1.2.1 Hematopoietic
6.1.2.2 Mesenchymal
6.1.2.3 Neural
6.1.2.4 Epithelial/Skin
6.1.2.5 Others
6.1.3 Human Embryonic Stem Cells (HESCs)
6.1.4 Induced Pluripotent Stem Cells (iPSCs)
6.1.5 Very Small Embryonic Like Stem Cells
6.2 Global Stem Cell Market by Application
6.2.1 Market Overview
6.2.2 Regenerative Medicine
6.2.2.1 Neurology
6.2.2.2 Orthopedics
6.2.2.3 Oncology
6.2.2.4 Hematology
6.2.2.5 Cardiovascular and Myocardial Infraction
6.2.2.6 Injuries
6.2.2.7 Diabetes
6.2.2.8 Liver Disorder
6.2.2.9 Incontinence
6.2.2.10 Others
6.2.3 Drug Discovery and Development
6.3 Global Stem Cell Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Surgical Centers
6.3.3 Therapeutic Companies
6.3.4 Services Companies
6.3.5 Others
6.4 Global Stem Cell Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Stem Cell Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Stem Cell Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Stem Cell Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Stem Cell Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Stem Cell Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Athersys Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Mesoblast Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Biorestorative Therapies Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Pluristem Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Brainstorm Cell Limited.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 ViaCyte Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Gamida Cell
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 HOPE BIOSCIENCES
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cellular Biomedicine Group
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Smith+Nephew
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 MEDIPOST
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ANTEROGEN. C.O., LTD.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 NuVasive Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 RTI Surgical
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 AlloSource
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 JCR Pharmaceuticals Co. Ltd.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Takeda Pharmaceutical Company Limited
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global Stem Cell Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global market for stem cell attained a value of USD 19.41 billion.
The market is anticipated to grow at a CAGR of 14.5% during the forecast period of 2024-2032 to reach a value of USD 63.05 billion by 2032.
The market is being aided by the rising prevalence of various non-communicable diseases, the increasing investments in stem cell therapies, and the growing utilisation of human-induced pluripotent stem cells (iPSCs).
The market is expected to be driven by the increasing research activities in regenerative medicines, the treatment of various health-related issues through cell therapy, and the integration of the latest technologies in research and development (R&D) activities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major product types of stem cell in the industry are adult stem cell, human embryonic cell, and pluripotent stem cell, among others.
The significant treatment types in the market are allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy.
The various applications of stem cell are neurological disorders, orthopaedic treatments, oncology disorders, injuries and wounds, and cardiovascular disorders, among others.
The major players in the industry are Pluristem Therapeutics Inc., Thermo Fisher Scientific Inc., Cellular Engineering Technologies, Merck KGaA, Becton, Dickinson and Company, and STEMCELL Technologies Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER